Healthtech Pre-Seed Investors & VC Firms
1468 firms in this list, with a median first check of $250K. 393 of them lead rounds. Generated from verified public data and updated continuously.
JITO Angel Network
MumbaiPre-Seed–Seed
11 people
Main Sequence Ventures
SydneyPre-Seed–Series B
25 people
Energy & Environment Investment
TokyoPre-Seed–Growth
18 people
Launchpad Venture Group
BostonPre-Seed–Series A$8M – $10M
15 people
Good Friends
San FranciscoPre-Seed–Seed$250K – $1M
5 people
Halcyon
WashingtonPre-Seed–Seed
41 people
AIX Ventures
San FranciscoPre-Seed–Series A$1M – $5M
13 people
KT investment Inc.
SeoulPre-Seed–Series B
IGNIA
Mexico CityPre-Seed–Series A$100K – $5M
20 people
Portland Seed Fund
PortlandPre-Seed–Series A$25K
5 people
SmartGateVC
GlendalePre-Seed–Seed$100K – $5M
20 people
OSAKA University Venture Capital
OsakaPre-Seed–Growth
20 people
Microtraction
LagosPre-Seed–Series A$100K
10 people
FoodLabs
BerlinPre-Seed–Series B
23 people
Unruly Capital
LondonPre-Seed–Seed
3 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
35 people
BoxOne Ventures
MontréalPre-Seed–Series A$500K
9 people
EWOR
BerlinPre-Seed–Seed$500K
39 people
New Stack Ventures
ChicagoPre-Seed–Seed$500K – $1.5M
15 people
A-Level Capital
BaltimorePre-Seed–Series B$40K – $100K
40 people
PSV
Kongens LyngbyPre-Seed–Seed$75.6K – $864K
33 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
26 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
IDC Ventures
MiamiPre-Seed–Growth
42 people
Related lists
Pre-Seed Investors & VC Firms (5569)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Pre-Seed Investors & VC Firms in North America (3004)Pre-Seed Investors & VC Firms in United States (2671)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)AI & Machine Learning Pre-Seed Investors & VC Firms (2102)Fintech Pre-Seed Investors & VC Firms (1711)
Data sourced from public filings and firms' own websites — see our methodology.









































































































